Genentech

Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin

Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin

Bloomberg

Roche Settles Claims Over Genentech’s Raptiva Psoriasis Drug, Lawyer Says

Roche Settles Claims Over Genentech’s Raptiva Psoriasis Drug, Lawyer Says

Bloomberg

Regeneron settles with Genentech over eye drug

Regeneron settles with Genentech over eye drug

Yahoo/AP

New Setback for Avastin as Breast Cancer Treatment

New Setback for Avastin as Breast Cancer Treatment

NY Times, NY

Big promise is seen in 2 new breast cancer drugs

Big promise is seen in 2 new breast cancer drugs

Yahoo/AP

Genmab says rivals appeal U.S. ruling in patent suit

Genmab says rivals appeal U.S. ruling in patent suit

Reuters

F.D.A. Revokes Approval of Avastin as Breast Cancer Drug

F.D.A. Revokes Approval of Avastin as Breast Cancer Drug

NY Times, NY

VA Reinstates Avastin Usage For Eye Disease

VA Reinstates Avastin Usage For Eye Disease

Pharmalot

Curis Earns $8 Million Milestone As NDA Accepted By FDA

Curis Earns $8 Million Milestone As NDA Accepted By FDA

Seeking Alpha

Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor

Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor

Seeking Alpha